Drug
Khk4951
Khk4951: highest development phase Phase 2, developed by Kyowa Kirin. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Kyowa Kirin
Trials
| Drug | Phase | Indication |
|---|---|---|
| KHK4951 NCT06116916 | Phase 2 | Diabetic Macular Edema (DME) |
| KHK4951 NCT06116890 | Phase 2 | Neovascular Age-Related Macular Degeneration (nAMD) |
Latest
No recent events.
Follow Khk4951 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.